Journey Medical Corp expected to post a loss of 10 cents a share - Earnings Preview

Journey Medical

09/08/2025 01:20

Journey Medical Corp DERM.OQ DERM.O is expected to  show a rise in quarterly revenue when it reports  results on August 12 for the period ending June 30 2025

The Scottsdale Arizona-based  company is expected to report a 0.5% increase in revenue to $14.933 million from $14.86 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Journey Medical Corp is for a loss of 10 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Journey Medical Corp is $10.00, about 24.3% above its last closing price of $7.57

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.23
-0.24
-0.18
Beat
24.2
Dec. 31 2025
-0.35
-0.15
Beat
57.4
Sep. 30 2024
-0.14
-0.15
-0.17
Missed
-15.3​
Jun. 30 2024
-0.14
-0.14
-0.17
Missed
-18.6
​​Mar. 31 2024
-0.23
-0.23
-0.53
Missed
-125.5
Dec. 31 2023
-0.09
-0.08
-0.12
Missed
-56.5​
Sep. 30 2023
-0.11
-0.15
0.80
Beat
616.1
Jun. 30 2023
-0.35
-0.33
-0.29
Beat
13.4

This summary was machine generated August 9 at 00:20 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)